Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026GlobeNewsWire · 4 days ago
Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain StockZacks Investment Research · Aug 18, 2026
Outset Medical, Inc. (OM) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 7, 2026
Outset Medical Q2 Earnings Call HighlightsMarketBeat · Aug 7, 2026
Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research · Aug 6, 2026
Outset Medical Reports Second Quarter 2026 ResultsGlobeNewsWire · Aug 6, 2026Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.72 | -$0.80 | Miss |
| May 7, 2026 | -$0.79 | -$0.83 | Miss |
| Feb 11, 2026 | -$0.67 | -$0.84 | Miss |
| Nov 10, 2025 | -$0.66 | -$0.69 | Miss |
| Aug 6, 2025 | -$0.98 | -$0.84 | Beat |
| May 7, 2025 | -$0.95 | -$3.24 | Miss |